 | Up a level |
2021
Nathan, Paul, Hassel, Jessica C., Rutkowski, Piotr, Baurain, Jean-Francois, Butler, Marcus O., Schlaak, Max, Sullivan, Ryan J., Ochsenreither, Sebastian, Dummer, Reinhard, Kirkwood, John M., Joshua, Anthony M., Sacco, Joseph J., Shoushtari, Alexander N., Orloff, Marlana, Piulats, Josep M., Milhem, Mohammed 
ORCID: 0000-0003-4663-6824, Salama, April K. S., Curti, Brendan, Demidov, Lev, Gastaud, Lauris, Mauch, Cornelia, Yushak, Melinda, Carvajal, Richard D., Hamid, Omid, Abdullah, Shaad E., Holland, Chris, Goodall, Howard and Piperno-Neumann, Sophie
(2021).
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
N. Engl. J. Med., 385 (13).
S. 1196 - 1207.
WALTHAM:
MASSACHUSETTS MEDICAL SOC.
ISSN 1533-4406
2020
D'Ambrosio, Lorenzo, Touati, Nathan, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Grignani, Giovanni, Flippot, Ronan, Czarnecka, Anna M., Piperno-Neumann, Sophie, Martin-Broto, Javier ORCID: 0000-0001-7350-6916, Sanfilippo, Roberta, Katz, Daniela, Duffaud, Florence, Vincenzi, Bruno, Stark, Daniel P., Mazzeo, Filomena, Tuchscherer, Armin, Chevreau, Christine, Sherriff, Jenny, Estival, Anna, Litiere, Saskia, Sents, Ward, Ray-Coquard, Isabelle, Tolomeo, Francesco, Le Cesne, Axel, Rutkowski, Piotr, Stacchiotti, Silvia, Kasper, Bernd, Gelderblom, Hans and Gronchi, Alessandro
(2020).
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Cancer, 126 (11).
S. 2637 - 2648.
HOBOKEN:
WILEY.
ISSN 1097-0142